Meridian Bioscience
(NASDAQ:VIVO)
Meridian Bioscience Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Meridian Bioscience Inc. - Common Stock recently split on Thursday, August 11, 2022 with a ratio of 1:10
$32.55
At close: Aug 11
$32.55
PreMarket: 4:15PM EDT
Day High/Low- - -
52 Week High/Low19.58 - 34.38
Open / Close- / -
Float / Outstanding27.5M / 43.7M
Vol / Avg.- / 786.1K
Mkt Cap1.4B
P/E33.21
50d Avg. Price30.85
Div / Yield-
Payout Ratio-
EPS-0.17
Total Float27.5M

Meridian Bioscience (NASDAQ:VIVO), Quotes and News Summary

Meridian Bioscience (NASDAQ: VIVO)

Day High/Low- - -
52 Week High/Low19.58 - 34.38
Open / Close- / -
Float / Outstanding27.5M / 43.7M
Vol / Avg.- / 786.1K
Mkt Cap1.4B
P/E33.21
50d Avg. Price30.85
Div / Yield-
Payout Ratio-
EPS-0.17
Total Float27.5M
Sector: Health Care.Industry: Health Care Equipment & Supplies
Meridian Bioscience Inc is an integrated life science company. It develops and distributes diagnostic tests and reagents, as well as biologic substances used by pharmaceutical and biotechnology companies. Its Diagnostics segment manufactures tests primarily for gastrointestinal, viral, respiratory, & parasitic infectious diseases. Its testing platforms include isothermal DNA amplification, rapid immunoassays, and enzyme-linked immunoassays. The Life sciences segment sells b-antigens, antibodies, and reagents in bulk to other diagnostic manufacturers, the agriculture industry, and researchers. It also manufactures proteins that biopharmaceutical companies use in new drugs and vaccines. The entity has a business presence in the US and other countries.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Meridian Bioscience Questions & Answers

Q
How do I buy Meridian Bioscience (VIVO) stock?
A

You can purchase shares of Meridian Bioscience (NASDAQ: VIVO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Meridian Bioscience's (VIVO) competitors?
Q
What is the target price for Meridian Bioscience (VIVO) stock?
A

The latest price target for Meridian Bioscience (NASDAQ: VIVO) was reported by Cowen & Co. on Thursday, August 11, 2022. The analyst firm set a price target for 70.00 expecting VIVO to rise to within 12 months (a possible 115.05% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Meridian Bioscience (VIVO)?
A

The stock price for Meridian Bioscience (NASDAQ: VIVO) is $32.55 last updated August 11, 2022, 8:00 PM UTC.

Q
Does Meridian Bioscience (VIVO) pay a dividend?
A

The next Meridian Bioscience (VIVO) dividend date is projected to be Monday, August 22, 2022.

Q
When is Meridian Bioscience (NASDAQ:VIVO) reporting earnings?
A

Meridian Bioscience’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Meridian Bioscience (VIVO) going to split?
A

There is no upcoming split for Meridian Bioscience.

Q
What sector and industry does Meridian Bioscience (VIVO) operate in?
A

Meridian Bioscience is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.